Preparation

Teicoplanin Bradex 200 mg and 400 mg  powder and liquid for injection/infusion, solution 6 ml vial

 

Powder and liquid for injection/infusion, solution

• Powder: White to off-white freeze-dried powder.

• Liquid: Clear, colorless solution.

 

 

Indications

Teicoplanin Bradex is indicated for adults and children from birth for parenteral treatment of the following

infections (see sections 4.2, 4.4 and 5.1):

 

• complicated skin and soft tissue infections

• bone tissue and joint infections

• hospital-acquired pneumonia

• community acquired pneumonia

• complicated urinary tract infections

• infective endocarditis

• peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD)

• bacteremia arising in connection with any of the indications listed above.

 

Teicoplanin Bradex is also indicated as an alternative oral treatment for Clostridium difficile infection-associated diarrhea and colitis.

 

Storage

Powder and solution packaged for sale do not require special storage conditions.

 

Packaging

•200 mg, carton x 1 vial x 200 mg + 1 ampoule x 3 ml diluent.

•400 mg carton x 1 vial x 400 mg + 1 ampoule x 3 ml diluent

 

Item number

•Vnr: 120994 Teicoplanin Bradex 200 mg

•Vnr: 170679 Teicoplanin Bradex 400 mg

 

 

ATC code

J01XA02,

​

For more information and training materials:

 

 

​
 

​